SELLAS Life Sciences Group (SLS) Current Assets: 2011-2024
Historic Current Assets for SELLAS Life Sciences Group (SLS) over the last 9 years, with Sep 2024 value amounting to $24.0 million.
- SELLAS Life Sciences Group's Current Assets rose 361.95% to $24.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $24.0 million, marking a year-over-year increase of 361.95%. This contributed to the annual value of $3.2 million for FY2023, which is 82.14% down from last year.
- According to the latest figures from Q3 2024, SELLAS Life Sciences Group's Current Assets is $24.0 million, which was up 95.37% from $12.3 million recorded in Q2 2024.
- In the past 5 years, SELLAS Life Sciences Group's Current Assets registered a high of $36.9 million during Q4 2020, and its lowest value of $3.2 million during Q4 2023.
- Moreover, its 3-year median value for Current Assets was $17.8 million (2022), whereas its average is $17.7 million.
- Per our database at Business Quant, SELLAS Life Sciences Group's Current Assets surged by 561.22% in 2021 and then slumped by 82.14% in 2023.
- Quarterly analysis of 5 years shows SELLAS Life Sciences Group's Current Assets stood at $36.9 million in 2020, then slumped by 37.59% to $23.0 million in 2021, then declined by 22.95% to $17.8 million in 2022, then slumped by 82.14% to $3.2 million in 2023, then skyrocketed by 361.95% to $24.0 million in 2024.
- Its last three reported values are $24.0 million in Q3 2024, $12.3 million for Q2 2024, and $21.5 million during Q1 2024.